Even more exciting, in live animal models (VEGFR2-luc transgenic mice implanted with 4T1 cells), antagomir-21 slowed tumor angiogenesis—basically cutting off the tumor’s blood supply—by blocking the HIF-1α/VEGF/VEGFR2 pathway [165]. The gene discussed is KDR; the disease is neoplasm.